Drugs / Ketoacid
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT01496092 | Apr 2011 → Dec 2012 | — | Peking University First Hospital | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT06392516 | Apr → Aug 2024 | dialysis disequilibrium syndrome | RSUP Fatmawati | Unknown | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 0 | NCT06796660 Background | Sep 2025 → Dec 2027 expected | chronic kidney disease | Liu Zhanghong | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | -Keto acid | “Dietary Nutrition: α-Keto acid tablets (2.6 g tid) may be used.” NCT06796660 ↗ |
| Route | Other | “will be given parenteral ketoacid analogues intradialytics two times a week” NCT06392516 ↗ |